ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Absentfriend
|
339 |
141K |
3 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
339
|
141K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL
|
|
Absentfriend
|
45 |
17K |
2 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
45
|
17K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the Deal, what do we need?
|
|
Absentfriend
|
16 |
8.2K |
5 |
12/12/21 |
12/12/21 |
ASX - By Stock
|
16
|
8.2K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
The Bene Deal
|
|
Absentfriend
|
17 |
7.6K |
0 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
17
|
7.6K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR Investor Meeting - Questions from HC
|
|
Absentfriend
|
122 |
40K |
6 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
122
|
40K
|
6
|
|
ASX - By Stock
|
PAR Biotech |
Re:
Heart Failure Inflammation
|
|
Absentfriend
|
13 |
6.1K |
7 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
13
|
6.1K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO Paul Rennie to transition to Non-Exec Chairman
|
|
Absentfriend
|
49 |
20K |
5 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
49
|
20K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO Paul Rennie to transition to Non-Exec Chairman
|
|
Absentfriend
|
49 |
20K |
10 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
49
|
20K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
mowing the lawn
|
|
Absentfriend
|
13 |
3.3K |
1 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
13
|
3.3K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
mowing the lawn
|
|
Absentfriend
|
13 |
3.3K |
3 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
13
|
3.3K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
mowing the lawn
|
|
Absentfriend
|
13 |
3.3K |
5 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
13
|
3.3K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
mowing the lawn
|
|
Absentfriend
|
13 |
3.3K |
8 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
13
|
3.3K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Absentfriend
|
4.3K |
3.8M |
6 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Absentfriend
|
191 |
77K |
15 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
77K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Absentfriend
|
191 |
77K |
16 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
77K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Absentfriend
|
191 |
77K |
6 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
77K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Absentfriend
|
191 |
77K |
12 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
77K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Absentfriend
|
150 |
75K |
1 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
150
|
75K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Absentfriend
|
150 |
75K |
21 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
75K
|
21
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Phase 2 Synovial Fluid Biomarker Study Update
|
|
Absentfriend
|
76 |
25K |
6 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
76
|
25K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
Absentfriend
|
294 |
119K |
1 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
294
|
119K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
Absentfriend
|
294 |
119K |
0 |
10/10/21 |
10/10/21 |
ASX - By Stock
|
294
|
119K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
Absentfriend
|
294 |
119K |
3 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
294
|
119K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
iPPS and the Nuclear Submarines
|
|
Absentfriend
|
3 |
1.6K |
4 |
26/09/21 |
26/09/21 |
ASX - By Stock
|
3
|
1.6K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Pirate Day Share Price 2021
|
|
Absentfriend
|
162 |
63K |
3 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
162
|
63K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Community Adoption / Mr Federer
|
|
Absentfriend
|
116 |
38K |
2 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
116
|
38K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: CHIKV study data published in Peer-Reviewed Journal
|
|
Absentfriend
|
24 |
9.0K |
6 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
24
|
9.0K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Community Adoption / Mr Federer
|
|
Absentfriend
|
116 |
38K |
15 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
116
|
38K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
CHIKUNGUNYA - PEER REVIEWED !!!
|
|
Absentfriend
|
38 |
14K |
1 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
38
|
14K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Prevalence of OA, Then -v- Now
|
|
Absentfriend
|
2 |
963 |
2 |
12/09/21 |
12/09/21 |
ASX - By Stock
|
2
|
963
|
2
|
|
ASX - By Stock
|
PAR |
Re:
CHIKUNGUNYA - PEER REVIEWED !!!
|
|
Absentfriend
|
38 |
14K |
1 |
12/09/21 |
12/09/21 |
ASX - By Stock
|
38
|
14K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
CHIKUNGUNYA - PEER REVIEWED !!!
|
|
Absentfriend
|
38 |
14K |
5 |
11/09/21 |
11/09/21 |
ASX - By Stock
|
38
|
14K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
CHIKUNGUNYA - PEER REVIEWED !!!
|
|
Absentfriend
|
38 |
14K |
2 |
11/09/21 |
11/09/21 |
ASX - By Stock
|
38
|
14K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
COO Disclosure
|
|
Absentfriend
|
4 |
2.1K |
1 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
4
|
2.1K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2021 Annual Report and Appendix 4E
|
|
Absentfriend
|
82 |
31K |
8 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
82
|
31K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Absentfriend
|
4.3K |
3.8M |
6 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Absentfriend
|
4.4K |
2.0M |
4 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
National MPS Society 35th Conference
|
|
Absentfriend
|
18 |
8.8K |
1 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
18
|
8.8K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
National MPS Society 35th Conference
|
|
Absentfriend
|
18 |
8.8K |
4 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
18
|
8.8K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Conference Call 3/8/21
|
|
Absentfriend
|
65 |
22K |
7 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
65
|
22K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Conference Call 3/8/21
|
|
Absentfriend
|
65 |
22K |
15 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
65
|
22K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Conference Call 3/8/21
|
|
Absentfriend
|
65 |
22K |
12 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
65
|
22K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
Absentfriend
|
150 |
61K |
13 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
150
|
61K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
Absentfriend
|
150 |
61K |
13 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
150
|
61K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
Absentfriend
|
150 |
61K |
18 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
150
|
61K
|
18
|
|
ASX - By Stock
|
PAR |
Re:
Where are PAR shareholders located?
|
|
Absentfriend
|
115 |
29K |
6 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
115
|
29K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Absentfriend
|
318 |
138K |
6 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
318
|
138K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Absentfriend
|
4.3K |
3.8M |
3 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
MOZZ Research - First Half 2021
|
|
Absentfriend
|
52 |
17K |
3 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
52
|
17K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: IND QUESTIONS RECEIVED FROM US FDA
|
|
Absentfriend
|
389 |
124K |
3 |
03/07/21 |
03/07/21 |
ASX - By Stock
|
389
|
124K
|
3
|
|